Y. Maeda

发表

Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer

Martin L. Miller, C. Sander, William Lee, 2015, Science.

Synergistic induction of NY-ESO-1 antigen expression by a novel histone deacetylase inhibitor, valproic acid, with 5-aza-2′-deoxycytidine in glioma cells

Kiyoshi Saito, Y. Kondo, T. Wakabayashi, 2009, Journal of Neuro-Oncology.

Selective inhibition of low-affinity memory CD8+ T cells by corticosteroids

J. Wolchok, D. Sugiyama, K. Panageas, 2019, The Journal of experimental medicine.

Adult-Onset Anti-Citrullinated Peptide Antibody-Negative Destructive Rheumatoid Arthritis Is Characterized by a Disease-Specific CD8+ T Lymphocyte Signature

H. Lähdesmäki, L. Elo, S. Mustjoki, 2020, Frontiers in Immunology.

Utility of the periareolar incision technique for breast reconstructive surgery in patients with breast cancer

Y. Maeda, T. Sakurai, Naohiko Oki, 2020, Surgery Today.

Pseudomesotheliomatous Carcinoma with a High Pleural Hyaluronic Acid Concentration Arising from a Primary Esophageal Squamous Cell Carcinoma

T. Takeshita, Y. Maeda, K. Shimizu, 2019, The American journal of case reports.

Tyrosine kinase inhibitor imatinib augments tumor immunity by depleting effector regulatory T cells

K. Iwaisako, J. Karbach, Hiromasa Morikawa, 2019, The Journal of experimental medicine.

Ephrin receptor A10 is a promising drug target potentially useful for breast cancers including triple negative breast cancers.

Y. Yoshioka, Y. Tsutsumi, H. Kamada, 2014, Journal of controlled release : official journal of the Controlled Release Society.

The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapies

M. Tsuboi, H. Mano, K. Goto, 2020, Nature Immunology.

Targets for Passive Immunotherapy Intracellular Tumor-Associated Antigens Represent Effective

H. Ikeda, L. Old, S. Gnjatic, 2012 .

Intracellular tumor-associated antigens represent effective targets for passive immunotherapy.

H. Ikeda, L. Old, S. Gnjatic, 2012, Cancer research.

Peptide Vaccine Induces Enhanced Tumor Growth Associated with Apoptosis Induction in CD8+ T Cells

L. Old, K. Takeda, H. Yagita, 2010, The Journal of Immunology.

T Cells + in CD8 Growth Associated with Apoptosis Induction Peptide Vaccine Induces Enhanced Tumor

L. Old, K. Takeda, H. Yagita, 2010 .

An Anti-Human Lutheran Glycoprotein Phage Antibody Inhibits Cell Migration on Laminin-511: Epitope Mapping of the Antibody

K. Hui, M. Nomizu, Fumihiko Katagiri, 2017, PloS one.

Cancer/testis antigens are novel targets of immunotherapy for adult T-cell leukemia/lymphoma.

R. Ueda, L. Old, A. Utsunomiya, 2012, Blood.

Anti-COX-2 autoantibody is a novel biomarker of immune aplastic anemia

S. Mustjoki, S. Ogawa, Xingmin Feng, 2022, Leukemia.

Annexin A4 is a possible biomarker for cisplatin susceptibility of malignant mesothelioma cells.

Y. Yoshioka, Y. Tsutsumi, H. Kamada, 2012, Biochemical and biophysical research communications.

Management of Crohn’s disease relapse during neoadjuvant chemotherapy for bilateral breast cancer: a case report

Y. Maeda, H. Jinno, A. Matsumoto, 2022, Oxford medical case reports.

Epidermal growth factor receptor localized to exosome membranes as a possible biomarker for lung cancer diagnosis.

Y. Yoshioka, Y. Tsutsumi, H. Kamada, 2013, Die Pharmazie.

Detection of self-reactive CD8+ T cells with an anergic phenotype in healthy individuals

D. Sugiyama, D. Adeegbe, S. Sakaguchi, 2014, Science.

Two FOXP3+CD4+ T cell subpopulations distinctly control the prognosis of colorectal cancers

M. Hattori, K. Honda, Y. Doki, 2016, Nature Medicine.

Depletion of central memory CD8+ T cells might impede the antitumor therapeutic effect of Mogamulizumab

T. Shimamura, Y. Doki, S. Iida, 2021, Nature Communications.

Unexpected central-memory CD8+ T cell reduction hampers the antitumor efficacy of mogamulizumab (anti-CC chemokine receptor 4 mAb) treatment

T. Shimamura, Y. Doki, S. Iida, 2020 .

Model-based clustering for flow and mass cytometry data with clinical information

Ko Abe, Kodai Minoura, Hiroyoshi Nishikawa, 2020, BMC Bioinformatics.

The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapies

M. Tsuboi, K. Goto, G. Ishii, 2020, Nature Immunology.

Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments.

M. Tsuboi, H. Kono, Y. Yatabe, 2022, Cancer cell.

The cancer epigenome: Non‐cell autonomous player in tumor immunity

K. Hinohara, Y. Maeda, Hiroyoshi Nishikawa, 2022, Cancer science.

Efficacy and Safety of Palbociclib and Fulvestrant in Japanese Patients With ER+/HER2− Advanced/Metastatic Breast Cancer

T. Okumura, Y. Maeda, T. Sakurai, 2019, In Vivo.

Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+ regulatory T cells, evoking antitumor immune responses in humans

J. Karbach, Y. Kanakura, D. Sugiyama, 2013, Proceedings of the National Academy of Sciences.

Scientific category: Immunobiology Cancer/testis antigens are novel targets of immunotherapy for adult T-cell leukemia/lymphoma

R. Ueda, L. Old, A. Utsunomiya, 2016 .

Model-based cell clustering and population tracking for time-series flow cytometry data

Teppei Shimamura, Yuka Maeda, Ko Abe, 2019, BMC Bioinformatics.

Expression of Eph receptor A10 is correlated with lymph node metastasis and stage progression in breast cancer patients

Y. Yoshioka, Y. Tsutsumi, H. Kamada, 2013, Cancer medicine.

CYBERTRACK2.0: zero-inflated model-based cell clustering and population tracking method for longitudinal mass cytometry data

Teppei Shimamura, Yuka Maeda, Ko Abe, 2020, Bioinform..

Detection of self-reactive CD8+ T cells with an anergic phenotype in healthy individuals

D. Sugiyama, D. Adeegbe, S. Sakaguchi, 2014, Science.

Ephrin receptor A10 is a promising drug target potentially useful for breast cancers including triple negative breast cancers.

Y. Yoshioka, Y. Tsutsumi, H. Kamada, 2014, Journal of controlled release : official journal of the Controlled Release Society.